Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00063401
What this trial is testing

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
Eli Lilly and Company 39
Testing effectiveness (Phase 2)Study completedNCT03126812
What this trial is testing

Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IVPeritoneal CancerFallopian Tube Cancer
The Netherlands Cancer Institute 33
Not applicableStudy completedNCT01851928
What this trial is testing

Validation of a Nutrition Screening Tool

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 128
Not applicableStudy completedNCT06870539
What this trial is testing

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Who this might be right for
Cancer-related Cognitive DysfunctionCytomegaloviral InfectionFallopian Tube Carcinoma+2 more
Mayo Clinic 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800
What this trial is testing

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Who this might be right for
Fallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more
National Cancer Institute (NCI) 120
Not applicableUnknownNCT00897039
What this trial is testing

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Southeastern Gynecologic Oncology 60
Not applicableLooking for participantsNCT03862677
What this trial is testing

Determining Prognostic Immune Markers in Patients With Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Leiden University Medical Center 300
Testing effectiveness (Phase 2)Looking for participantsNCT06290193
What this trial is testing

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaOvarian Carcinoma+7 more
Memorial Sloan Kettering Cancer Center 86
Not applicableUnknownNCT03116867
What this trial is testing

Sonosalpingography After Hysteroscopic Tubal Occlusion

Who this might be right for
Fallopian Tube Occlusion
Ain Shams University 56
Not applicableUnknownNCT01372787
What this trial is testing

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
AnxietyFatigueNausea and Vomiting+20 more
Gynecologic Oncology Group 103
Testing effectiveness (Phase 2)Study completedNCT03029598
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
University of Washington 29
Early research (Phase 1)WithdrawnNCT02277392
What this trial is testing

A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian, Fallopian Tube and Peritoneal Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Testing effectiveness (Phase 2)Study completedNCT00281632
What this trial is testing

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Who this might be right for
Peritoneal CancerOvarian CancerNeoplasms, Ovarian+1 more
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT00248248
What this trial is testing

DOXIL for Consolidation Therapy in Ovarian Cancer.

Who this might be right for
Ovarian Neoplasm
Southeastern Gynecologic Oncology 45
Early research (Phase 1)Ended earlyNCT01952249
What this trial is testing

Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Who this might be right for
Primary Peritoneal Carcinoma
OncoMed Pharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)Study completedNCT01220154
What this trial is testing

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
David O'Malley 9
Not applicableStudy completedNCT01391351
What this trial is testing

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

Who this might be right for
Carcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
Centre Francois Baclesse 107
Early research (Phase 1)Ended earlyNCT00303888
What this trial is testing

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Yale University 31
Next Page